An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.


OBJECTIVE To assess the ability of patients, during an acute migraine attack, to successfully self-inject a single dose of sumatriptan using a novel sumatriptan auto-injector (Alsuma(®)), and to evaluate the safety, tolerability, and effectiveness of this sumatriptan auto-injector during an acute migraine attack. BACKGROUND This sumatriptan auto-injector… (More)
DOI: 10.1111/j.1526-4610.2012.02295.x


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.